DaVita Inc. (DVA) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Care Facilities Branche. Der Hauptsitz des Unternehmens ist in Denver, CO, United States. Der aktuelle CEO ist Javier J. Rodriguez.
DVA hat IPO-Datum 1995-10-31, 76,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $9.99B.
DaVita Inc. is a leading provider of kidney dialysis and related renal care services, operating a global network of outpatient dialysis centers and providing comprehensive treatment solutions for patients with chronic kidney failure and end-stage renal disease. The company operates approximately 2,815 dialysis centers across the United States serving around 203,100 patients, along with 339 centers in ten countries internationally serving approximately 39,900 patients. Beyond dialysis services, DaVita offers clinical laboratory testing, vascular access services, disease management programs, acute inpatient dialysis services in approximately 850 hospitals, and integrated care arrangements for thousands of patients. The company also operates clinical laboratories and provides physician services and comprehensive kidney care management. Headquartered in Denver, Colorado, DaVita Inc. is a major player in the nephrology care market, delivering both clinical and administrative services to support patients with serious kidney conditions.
